Last reviewed · How we verify

NCT05178212: AW-PP_Covid

Characteristics and Outcomes of Patients With COVID-19 Treated With HFNO and Prone Positioning

Completed Last updated 27 January 2026
What this trial tests

trial in COVID-19 in 600 participants. Completed in 31 December 2022.

Timeline
15 April 2020
Primary endpoint
30 December 2021
31 December 2022

Quick facts

Lead sponsorHospital Privado de Comunidad de Mar del Plata
StatusCompleted
Study typeOBSERVATIONAL
Enrollment600
Start date15 April 2020
Primary completion30 December 2021
Estimated completion31 December 2022
Sites1 location across Argentina

Conditions studied

Sponsor

Hospital Privado de Comunidad de Mar del Plata

Who can join

18 and older, any sex, with COVID-19 or Respiratory Failure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A subset of patients with COVID-19 develops acute respiratory failure and acute respiratory distress syndrome (ARDS) (1). The use of invasive mechanical ventilation for the treatment of these conditions is associated with high mortality rates (2,3). The use of high-flow nasal oxygen therapy (HFNO) and awake prone position (AW-PP) could to decrease the need for endotracheal intubation and other adverse clinical outcomes (4-6). The aim of this study is to evaluate the clinical results of the simultaneous application of high-flow nasal oxygen therapy HFNO and awake-prone position in a cohort of patients with severe respiratory failure secondary to COVID-19 on relevant clinical outcomes, and to assess risk factors of treatment failure defined as requirement of invasive mechanical ventilation.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Effectiveness of bundle of care on tolerance of awake-prone positioning in patients with acute respiratory failure. A multicenter observational study.
    Olmos M, Fuentes N, Busico M, Gallardo A, et al · · 2025 · cited 7× · PMID 39961842 · DOI 10.1007/s00134-025-07804-5
  2. Comparison of the effectiveness of awake-prone positioning and high-flow nasal oxygen in patients with COVID-19-related acute respiratory failure between different waves.
    Esperatti M, Olmos M, Busico M, Gallardo A, et al · · 2024 · cited 3× · PMID 39442133 · DOI 10.62675/2965-2774.20240065-en
  3. A predictive model for early intubation in patients with COVID-19-induced acute hypoxemic respiratory failure under awake prone position.
    Morales-Quinteros L, Fuentes NA, Muriel A, Olmos M, et al · · 2025 · PMID 41284115 · DOI 10.1186/s13613-025-01602-4

Verify or expand the search:

Other recruiting trials for COVID-19

Currently open trials in the same condition.

Other Hospital Privado de Comunidad de Mar del Plata trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05178212.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing